Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.4860
-0.0139 (-2.78%)
At close: Sep 18, 2026
Vaxart Market Cap
Vaxart has a market cap or net worth of $118.19 million as of September 18, 2026. Its market cap has increased by 33.35% in one year.
Market Cap
118.19M
Enterprise Value
66.76M
Revenue
243.07M
Ranking
n/a
PE Ratio
3.00
Stock Price
$0.49
ChartMarket Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 118.19M, an increase of 95.85%. That is a compound annual growth rate of 8.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 118.19M | 42.18% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 301.57M |
| Northwest Biotherapeutics | 282.28M |
| Glorywin Entertainment Group | 234.77M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 79.81M |
| Nuo Therapeutics | 60.06M |
| Sangamo Therapeutics | 58.46M |
| Arch Biopartners | 44.48M |